AIGH Capital Management’s Heron Therapeutics HRTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$6.23M Buy
3,009,257
+231,057
+8% +$478K 2.8% 16
2025
Q1
$6.11M Buy
+2,778,200
New +$6.11M 2.53% 13